Clinakos Inc. is proud to be recognized as a key player in shaping the future of AI-driven oncology alongside market leaders including Nvidia, ConcertAI, Oracle, PathAI, CureMatrix, Tempus, GE Healthcare, Siemens Healthineers, Medrtonic, Roche, Insilico Medicone, and others.
According to the latest AI in Oncology Market report from MarketsandMarkets, the global market is set to grow from US $2.45 billion in 2024 to US $11.52 billion by 2030, achieving an impressive 29.4% CAGR.
This rapid growth is fueled by AI breakthroughs in:
Early cancer detection
Precision oncology & personalized care
Clinical decision support
AI-enabled drug discovery
At Clinakos, our mission is clear: to harness the power of real-world data, advanced analytics, and AI technology to empower healthcare providers, researchers, and life sciences organizations with actionable insights that improve patient outcomes.
Being listed alongside global technology and healthcare leaders is both an honor and a testament to our team’s relentless commitment to innovation in cancer care.
Curious to learn more? Read the full report here
